Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia

Richard F. Ammar, David D. Gutterman, Leonard A. Brooks, Kevin C. Dellsperger

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Previous studies showed that nitric oxide (NO) plays an important role in coronary arteriolar dilation to increases in myocardial oxygen consumption (MVO2). We sought to evaluate coronary microvascular responses to endothelium-dependent and to endothelium-independent vasodilators in an in vivo model. Microvascular diameters were measured using intravital microscopy in 10 normal (N) and 9 hyperglycemic (HG; 1 wk alloxan, 60 mg/kg iv) dogs during suffusion of acetylcholine (1, 10, and 100 μM) or nitroprusside (1, 10, and 100 μM) to test the effects on endothelium-dependent and -independent dilation. During administration of acetylcholine, coronary arteriolar dilation was impaired in HG, but was normal during administration of nitroprusside. To examine a physiologically important vasomotor response, 10 N and 7 HG control, 5 HG and 5 N during superoxide dismutase (SOD), and 5 HG and 4 N after SQ29,548 (SQ; thromboxane A2/prostaglandin H2 receptor antagonist) dogs were studied at three levels of MVO2: at rest, during dobutamine (DOB; 10 μg · kg-1 · min-1 iv), and during DOB with rapid atrial pacing (RAP; 280 ± 10 beats/min). During dobutamine, coronary arterioles dilated similarly in all groups, and the increase in MVO2 was similar among the groups. However, during the greater metabolic stimulus (DOB+RAP), coronary arterioles in N dilated (36 ± 4% change from diameter at rest) significantly more than HG (16 ± 3%, P < 0.05). In HG+SQ and in HG+SOD, coronary arterioles dilated similarly to N, and greater than HG (P < 0.05). MVO2 during DOB+RAP was similar among groups. Normal dogs treated with SOD and SQ29,548 were not different from untreated N dogs. Thus, in HG dogs, dilation of coronary arterioles is selectively impaired in response to administration of the endothelium-dependent vasodilator acetylcholine and during increases in MVO2.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume279
Issue number4 42-4
StatePublished - Dec 7 2000
Externally publishedYes

Fingerprint

Arterioles
Hyperglycemia
Dilatation
Dogs
Acetylcholine
Superoxide Dismutase
Endothelium
Dobutamine
Nitroprusside
Prostaglandin H2 Receptors Thromboxane A2
Endothelium-Dependent Relaxing Factors
Alloxan
Vasodilator Agents
Oxygen Consumption
Nitric Oxide

Keywords

  • Coronary microcirculation
  • Diabetes
  • Dobutamine
  • SQ29,548
  • Superoxide
  • Superoxide dismutase

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia. / Ammar, Richard F.; Gutterman, David D.; Brooks, Leonard A.; Dellsperger, Kevin C.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 279, No. 4 42-4, 07.12.2000.

Research output: Contribution to journalArticle

Ammar, Richard F. ; Gutterman, David D. ; Brooks, Leonard A. ; Dellsperger, Kevin C. / Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia. In: American Journal of Physiology - Endocrinology and Metabolism. 2000 ; Vol. 279, No. 4 42-4.
@article{1f72c96a7171472e8d8ea74546448c32,
title = "Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia",
abstract = "Previous studies showed that nitric oxide (NO) plays an important role in coronary arteriolar dilation to increases in myocardial oxygen consumption (MVO2). We sought to evaluate coronary microvascular responses to endothelium-dependent and to endothelium-independent vasodilators in an in vivo model. Microvascular diameters were measured using intravital microscopy in 10 normal (N) and 9 hyperglycemic (HG; 1 wk alloxan, 60 mg/kg iv) dogs during suffusion of acetylcholine (1, 10, and 100 μM) or nitroprusside (1, 10, and 100 μM) to test the effects on endothelium-dependent and -independent dilation. During administration of acetylcholine, coronary arteriolar dilation was impaired in HG, but was normal during administration of nitroprusside. To examine a physiologically important vasomotor response, 10 N and 7 HG control, 5 HG and 5 N during superoxide dismutase (SOD), and 5 HG and 4 N after SQ29,548 (SQ; thromboxane A2/prostaglandin H2 receptor antagonist) dogs were studied at three levels of MVO2: at rest, during dobutamine (DOB; 10 μg · kg-1 · min-1 iv), and during DOB with rapid atrial pacing (RAP; 280 ± 10 beats/min). During dobutamine, coronary arterioles dilated similarly in all groups, and the increase in MVO2 was similar among the groups. However, during the greater metabolic stimulus (DOB+RAP), coronary arterioles in N dilated (36 ± 4{\%} change from diameter at rest) significantly more than HG (16 ± 3{\%}, P < 0.05). In HG+SQ and in HG+SOD, coronary arterioles dilated similarly to N, and greater than HG (P < 0.05). MVO2 during DOB+RAP was similar among groups. Normal dogs treated with SOD and SQ29,548 were not different from untreated N dogs. Thus, in HG dogs, dilation of coronary arterioles is selectively impaired in response to administration of the endothelium-dependent vasodilator acetylcholine and during increases in MVO2.",
keywords = "Coronary microcirculation, Diabetes, Dobutamine, SQ29,548, Superoxide, Superoxide dismutase",
author = "Ammar, {Richard F.} and Gutterman, {David D.} and Brooks, {Leonard A.} and Dellsperger, {Kevin C.}",
year = "2000",
month = "12",
day = "7",
language = "English (US)",
volume = "279",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4 42-4",

}

TY - JOUR

T1 - Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia

AU - Ammar, Richard F.

AU - Gutterman, David D.

AU - Brooks, Leonard A.

AU - Dellsperger, Kevin C.

PY - 2000/12/7

Y1 - 2000/12/7

N2 - Previous studies showed that nitric oxide (NO) plays an important role in coronary arteriolar dilation to increases in myocardial oxygen consumption (MVO2). We sought to evaluate coronary microvascular responses to endothelium-dependent and to endothelium-independent vasodilators in an in vivo model. Microvascular diameters were measured using intravital microscopy in 10 normal (N) and 9 hyperglycemic (HG; 1 wk alloxan, 60 mg/kg iv) dogs during suffusion of acetylcholine (1, 10, and 100 μM) or nitroprusside (1, 10, and 100 μM) to test the effects on endothelium-dependent and -independent dilation. During administration of acetylcholine, coronary arteriolar dilation was impaired in HG, but was normal during administration of nitroprusside. To examine a physiologically important vasomotor response, 10 N and 7 HG control, 5 HG and 5 N during superoxide dismutase (SOD), and 5 HG and 4 N after SQ29,548 (SQ; thromboxane A2/prostaglandin H2 receptor antagonist) dogs were studied at three levels of MVO2: at rest, during dobutamine (DOB; 10 μg · kg-1 · min-1 iv), and during DOB with rapid atrial pacing (RAP; 280 ± 10 beats/min). During dobutamine, coronary arterioles dilated similarly in all groups, and the increase in MVO2 was similar among the groups. However, during the greater metabolic stimulus (DOB+RAP), coronary arterioles in N dilated (36 ± 4% change from diameter at rest) significantly more than HG (16 ± 3%, P < 0.05). In HG+SQ and in HG+SOD, coronary arterioles dilated similarly to N, and greater than HG (P < 0.05). MVO2 during DOB+RAP was similar among groups. Normal dogs treated with SOD and SQ29,548 were not different from untreated N dogs. Thus, in HG dogs, dilation of coronary arterioles is selectively impaired in response to administration of the endothelium-dependent vasodilator acetylcholine and during increases in MVO2.

AB - Previous studies showed that nitric oxide (NO) plays an important role in coronary arteriolar dilation to increases in myocardial oxygen consumption (MVO2). We sought to evaluate coronary microvascular responses to endothelium-dependent and to endothelium-independent vasodilators in an in vivo model. Microvascular diameters were measured using intravital microscopy in 10 normal (N) and 9 hyperglycemic (HG; 1 wk alloxan, 60 mg/kg iv) dogs during suffusion of acetylcholine (1, 10, and 100 μM) or nitroprusside (1, 10, and 100 μM) to test the effects on endothelium-dependent and -independent dilation. During administration of acetylcholine, coronary arteriolar dilation was impaired in HG, but was normal during administration of nitroprusside. To examine a physiologically important vasomotor response, 10 N and 7 HG control, 5 HG and 5 N during superoxide dismutase (SOD), and 5 HG and 4 N after SQ29,548 (SQ; thromboxane A2/prostaglandin H2 receptor antagonist) dogs were studied at three levels of MVO2: at rest, during dobutamine (DOB; 10 μg · kg-1 · min-1 iv), and during DOB with rapid atrial pacing (RAP; 280 ± 10 beats/min). During dobutamine, coronary arterioles dilated similarly in all groups, and the increase in MVO2 was similar among the groups. However, during the greater metabolic stimulus (DOB+RAP), coronary arterioles in N dilated (36 ± 4% change from diameter at rest) significantly more than HG (16 ± 3%, P < 0.05). In HG+SQ and in HG+SOD, coronary arterioles dilated similarly to N, and greater than HG (P < 0.05). MVO2 during DOB+RAP was similar among groups. Normal dogs treated with SOD and SQ29,548 were not different from untreated N dogs. Thus, in HG dogs, dilation of coronary arterioles is selectively impaired in response to administration of the endothelium-dependent vasodilator acetylcholine and during increases in MVO2.

KW - Coronary microcirculation

KW - Diabetes

KW - Dobutamine

KW - SQ29,548

KW - Superoxide

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=0033679615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033679615&partnerID=8YFLogxK

M3 - Article

VL - 279

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4 42-4

ER -